• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Development of slow release reagent of NFkB decoy oligodeoxynucleotides for the treatment of rheumatic arthritis

Research Project

Project/Area Number 13558109
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Biomedical engineering/Biological material science
Research InstitutionOSAKA UNIVERSITY

Principal Investigator

KANEDA Yasufumi  Osaka University, Graduate School of Medicine, Professor, 医学系研究科, 教授 (10177537)

Co-Investigator(Kenkyū-buntansha) SANO Akihiko  Sumitomo Pharmaceuticals Co. Ltd., Formulation Research Laboratories, 製剤技術研究所・創剤研究グループ, 主任研究員
MIRISHITA Ryuichi  Osaka University, Graduate School of Medicine, Professor, 医学系研究科, 教授 (40291439)
Project Period (FY) 2001 – 2002
Keywordsdecoy oligodeoxynucleotides / NFκB / drug delivery / polymer / molecular therapy
Research Abstract

We attempted to prolong release of NFkB oligodeoxynudeotid.es without degradation. First, we tested the efficiency of introduction of FITC-labeled oligonucleotides into cultured cells using atelocollagen. No fluorescence was detected at 48 hours after the transfer to HeLa, BHK-21 and human tongue cancer cell line SAS. Then, we developed HVJ (hemagglutinating virus of Japan ; Sendai virus) envelope vector which can introduce synthetic oligonucleotides, proteins, peptides and chemical drugs as well as genes. FITC-labeled oligonucleotides were incorporated into HVJ envelope vector by the treatment of mild detergent and centrifugation. Ten minutes after incubation of those cultured cells described above with the HVJ envelope vector, fluorescence was observed in almost all the nuclei of the cells. When NFkB decoy oligonucleotides were introduced into cancer cells such as SAS and HeLa cells using HVJ envelope vector, apoptosis after irradiation was enhanced by the suppression of NFkB-induced … More gene expression. When FITC-labeled NFkB decoy oligonucleotides were introduced into the joint space of Cynomolgus monkeys using HVJ envelope vector, fluorescence was detected at both synovium and articular cartilage. Next, HVJ envelope vector was embedded with various polymers. First, without polymer, HVJ envelope vector reaches spleen by intravenous injection and FITC-oligonucleotides were detected at the marginal zone of mouse spleen. Then, the vector containing luciferase gene was decorated with protamine suifate and the complex was injected into tail vein of mouse. Gene expression was detected exclusively in lung, not in spleen. Furthermore, when HVJ envelope vector mixed with heparin was injected into muscle or brain directly, gene expression was approximately 5 fold increased than that without heparin. The effect of polymers on slow release of the vector is being investigated, but we have got preliminary data suggesting that cationic polymers may enhance slow release of HVJ envelope vector. Less

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Yamamoto, S.: "A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma"Cancer Gene Therapy. (in press). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomita, N.: "Targeted Gene Therapy for Rat Glomerulonephritis using HVJ-immunoliposomes"J.Gene Medicine. 4. 527-535 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kaneda, Y.: "HVJ (hemagglutinating virus of Japan) envelope vector as a versatile gene delivery system"Molecular Therapy. 6. 219-226 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura, H.: "Prevention and regeneration of atopic dermatitis by ointment containing NFkB decoy oligonucleotides in NC/Nga atopic mouse model"Gene Therapy. 9. 1221-1229 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endoh, M.: "Fetal gene transfer by intra-uterine injection with microbubble-enhanced ultrasound"Molecular Therapy. 5. 501-505 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Taniyama Y.: "Local delivery of plasmid DNA into rat carotid artery using ultrasound"Circulation. 105. 1233-1239 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kaneda, Y.: "Pharmaceutical Gene Delivery Systems"Alain Rolland and Sean Sullivan(in press). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Taniyama, Y., Tachibana, K., Hiraoka, K., Nainba, T., Yamasaki, K., Hashiya, N., Aoki, M., Ogihara, T., Kaneda, Y., and Morishita, R.: "Local delivery of plasmid DNA into rat carotid artery using ultrasound"Circulation. 105. 1233-1239 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Endoh, M., Koibuchi, N., Sato, M., Morishita, R., Kanzaki, T., Murata, Y. and Kaneda, Y: "Fetal gene transfer by intra-uterine injection with microbubble-enhanced ultrasound"Molecular Therapy. 5. 501-505 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tomita, N., Morishita, R, Yamamoto, K., Higaki, J., Dzau, V. J., Ogihara, T., and Kaneda, Y: "Targeted Gene Therapy for Rat Glomerulonephritis using HVJ-intmtsnoliposomes"J. Gene Medicine. 4. 527-535 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura, T., Morishita, R., Asai, T., Tsuboniwa, N., Aoki, M., Sakonju, H., Yainasaki, K., Hashiya, N., Kaneda, Y., and Ogihara, T: "Molecular strategy using cis-element decoy of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model."Gene Therapy. 9. 488-494 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tanjyama, Y, Tachibana, K., Hiraoka, K., Aoki, M., Yamamoto, S., Matsumoto, K., Nakamura, T., Ogihara, T., Kaneda,Y, and Morishita,: "Development of safe and efficient novel nonviral gene transfer using ultrasound ; enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle"Gene Therapy. 9. 372-380 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura, H., Morishita, R., and Kaneda, Y: "Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys"In Vivo. 16. 45-48 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kaneda, Y., Nakajima, T., Nishikawa, T., Yamamoto, S., Ikegami, H., Suzuki, N., Nakamura, H., Morishita, R, and Kotani, H: "HVJ (hemagglutinating virus of Japan) envelope vector as a versatile gene delivery system"Molecular Therapy. 6. 219-226 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi